Wayne Yetter

Director, InfuSystem Holdings, Inc. (INFU), Special Diversified Opportunities Inc. (SDOI), and MTG Biotherapeutics, Inc.

Wayne had a 30 year career in the pharmaceutical industry and held executive positions at Pfizer, Merck, Astra-Merck (now AstraZeneca) and Novartis.  His roles included VP, Marketing Operations and VP Far East and Pacific at Merck, founding CEO of Astra-Merck, and President and CEO of Novartis Pharmaceuticals Corp., the US division of Novartis AG.  He also served as COO of IMS Health, a healthcare market research data company, and as Chairman and CEO of Synavant, Inc. “spin-out” of IMS.  He has served as Chairman or Lead Independent Director of several public companies including Noven Pharmaceuticals, Transkaryotic Therapies, Matria Healthcare, and most recently NuPathe Inc. (each of these companies was acquired).  Wayne is currently a director of InfuSystem Holdings, Inc. (INFU), Special Diversified Opportunities Inc. (SDOI), and MTG Biotherapeutics, Inc.